Search results
Zacks Industry Outlook Highlights DaVita, Encompass Health, Option Care Health and The Pennant Group
Zacks via Yahoo Finance· 6 days agoThe Zacks Consensus Estimate for Encompass Health’s 2024 earnings suggests growth of 10.3%. The same...
Harrow Inc (HROW) Q1 2024 Earnings Call Transcript Highlights: Robust Growth and Strategic Advances
GuruFocus.com via Yahoo Finance· 7 hours agoThe company experienced a material impact on sales due to the Change Healthcare cyber-attack, with a significant financial hit in the millions of dollars. There is ongoing uncertainty with & ...
What Medicare beneficiaries need to know about generic medications
Fortune via AOL· 12 hours agoWhat’s happening with the cost of generics The price of generics can vary greatly, too, and Medicare...
Arcutis Biotherapeutics Inc (ARQT) Q1 2024 Earnings Call Transcript Highlights: Robust Growth ...
GuruFocus.com via Yahoo Finance· 7 hours agoFor Medicare Part D, discussions are ongoing, and coverage from some Part D plans is expected in the latter half of 2024, with further ...
Humana Options Trading: A Deep Dive into Market Sentiment - Humana (NYSE:HUM)
Benzinga· 5 days agoConsistent in their evaluation, an analyst from Oppenheimer keeps a Outperform rating on Humana with a target price of $370. Options are a riskier asset compared& ...
Earnings call: Royalty Pharma reports robust growth and strategic acquisitions
Investing.com· 6 days agoRoyalty Pharma (RPRX) has reported a significant growth of 14% in Royalty Receipts, amounting to...
Americans prepare to keep working through retirement
Newsweek· 7 days agoThe golden years might be over, as more and more Americans prepare to keep working through their retirement. In an Allianz Life study, 63 percent of...
Bernie Sanders Urges Ozempic Maker Novo Nordisk To Be Fair Over ‘Outrageously Expensive’ U.S. Drug...
Forbes· 2 days agoBernie Sanders has urged Denmark to rein in its most valuable company, Novo Nordisk, and force it to...
Summary and Key Considerations of Recent HHS-OIG Advisory Opinion on Pharmaceutical Patient...
JD Supra· 2 days agoIn an unprecedent move, OIG set a time limit for the advisory opinion, terminating it two years after the full implementation of the Medicare Part
Hotter inflation keeps mortgage rates higher, but housing inventory building: Fannie Mae
FOX Business· 2 days agoThere's no relief in sight for high borrowing costs as interest rate cuts are pushed further into...